Literature DB >> 32540905

αvβ8 integrin adhesion and signaling pathways in development, physiology and disease.

Joseph H McCarty1.   

Abstract

Cells must interpret a complex milieu of extracellular cues to modulate intracellular signaling events linked to proliferation, differentiation, migration and other cellular processes. Integrins are heterodimeric transmembrane proteins that link the extracellular matrix (ECM) to the cytoskeleton and control intracellular signaling events. A great deal is known about the structural and functional properties for most integrins; however, the adhesion and signaling pathways controlled by αvβ8 integrin, which was discovered nearly 30 years ago, have only recently been characterized. αvβ8 integrin is a receptor for ECM-bound forms of latent transforming growth factor β (TGFβ) proteins and promotes the activation of TGFβ signaling pathways. Studies of the brain, lung and immune system reveal that the αvβ8 integrin-TGFβ axis mediates cell-cell contact and communication within complex multicellular structures. Perturbing components of this axis results in aberrant cell-cell adhesion and signaling leading to the initiation of various pathologies, including neurodegeneration, fibrosis and cancer. As discussed in this Review, understanding the functions for αvβ8 integrin, its ECM ligands and intracellular effector proteins is not only an important topic in cell biology, but may lead to new therapeutic strategies to treat human pathologies related to integrin dysfunction.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Angiogenesis; Cancer; Extracellular matrix; Microenvironment; Pathophysiology

Year:  2020        PMID: 32540905      PMCID: PMC7328133          DOI: 10.1242/jcs.239434

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  137 in total

Review 1.  The diverse roles of integrins and their ligands in angiogenesis.

Authors:  R O Hynes; J C Lively; J H McCarty; D Taverna; S E Francis; K Hodivala-Dilke; Q Xiao
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

2.  Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.

Authors:  Sujata Lakhe-Reddy; Shenaz Khan; Martha Konieczkowski; George Jarad; Karen L Wu; Louis F Reichardt; Yoshimi Takai; Leslie A Bruggeman; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

3.  Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.

Authors:  Jennifer A Markovics; Jun Araya; Stephanie Cambier; David Jablons; Arthur Hill; Paul J Wolters; Stephen L Nishimura
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

4.  Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells.

Authors:  Naoki Takasaka; Robert I Seed; Anthony Cormier; Andrew J Bondesson; Jianlong Lou; Ahmed Elattma; Saburo Ito; Haruhiko Yanagisawa; Mitsuo Hashimoto; Royce Ma; Michelle D Levine; Jean Publicover; Rashaun Potts; Jillian M Jespersen; Melody G Campbell; Fraser Conrad; James D Marks; Yifan Cheng; Jody L Baron; Stephen L Nishimura
Journal:  JCI Insight       Date:  2018-10-18

5.  Cryo-EM Reveals Integrin-Mediated TGF-β Activation without Release from Latent TGF-β.

Authors:  Melody G Campbell; Anthony Cormier; Saburo Ito; Robert I Seed; Andrew J Bondesson; Jianlong Lou; James D Marks; Jody L Baron; Yifan Cheng; Stephen L Nishimura
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

6.  Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.

Authors:  Géraldine Guasch; Markus Schober; H Amalia Pasolli; Emily Belmont Conn; Lisa Polak; Elaine Fuchs
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

7.  The changing integrin expression and a role for integrin β8 in the chondrogenic differentiation of mesenchymal stem cells.

Authors:  Vanessa L S LaPointe; Amanda Verpoorte; Molly M Stevens
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

8.  Harnessing region-specific neurovascular signaling to promote germinal matrix vessel maturation and hemorrhage prevention.

Authors:  Devi Santhosh; Joe Sherman; Shafi Chowdhury; Zhen Huang
Journal:  Dis Model Mech       Date:  2019-11-11       Impact factor: 5.758

9.  Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection.

Authors:  Terry Jackson; Stuart Clark; Stephen Berryman; Alison Burman; Stephanie Cambier; Dezhi Mu; Stephen Nishimura; Andrew M Q King
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment.

Authors:  A Savar; S Acin; C L Gonzalez; T El-Sawy; O Mejia; Z Li; B Esmaeli; A Lacy-Hulbert; A K El-Naggar; J H McCarty; C Caulin
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

View more
  13 in total

1.  The β8 integrin cytoplasmic domain activates extracellular matrix adhesion to promote brain neurovascular development.

Authors:  Arpan De; John E Morales; Zhihua Chen; Sumod Sebastian; Joseph H McCarty
Journal:  Development       Date:  2022-03-18       Impact factor: 6.868

Review 2.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

3.  Mlc1-Expressing Perivascular Astrocytes Promote Blood-Brain Barrier Integrity.

Authors:  John E Morales; Arpan De; Alexandra A Miller; Zhihua Chen; Joseph H McCarty
Journal:  J Neurosci       Date:  2021-12-29       Impact factor: 6.709

4.  Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno-Associated Viral Vector rAAV9P1.

Authors:  Amelie Bauer; Matteo Puglisi; Dennis Nagl; Joel A Schick; Thomas Werner; Andreas Klingl; Jihad El Andari; Veit Hornung; Horst Kessler; Magdalena Götz; Dirk Grimm; Ruth Brack-Werner
Journal:  Adv Sci (Weinh)       Date:  2022-04-10       Impact factor: 17.521

5.  Modulation of αVβ6 integrin in osteoarthritis-related synovitis and the interaction with VTN(381-397 a.a.) competing for TGF-β1 activation.

Authors:  Michel G Malaise; Dominique de Seny; Federica Ciregia; Céline Deroyer; Gaël Cobraiville; Zelda Plener; Olivier Malaise; Philippe Gillet; Marianne Fillet
Journal:  Exp Mol Med       Date:  2021-02-01       Impact factor: 8.718

6.  The RGD-binding integrins αvβ6 and αvβ8 are receptors for mouse adenovirus-1 and -3 infection.

Authors:  Manuela Bieri; Rodinde Hendrickx; Michael Bauer; Bin Yu; Tania Jetzer; Birgit Dreier; Peer R E Mittl; Jens Sobek; Andreas Plückthun; Urs F Greber; Silvio Hemmi
Journal:  PLoS Pathog       Date:  2021-12-15       Impact factor: 6.823

Review 7.  Cooperative signaling between integrins and growth factor receptors in fibrosis.

Authors:  Horacio Maldonado; James S Hagood
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

8.  The vascular endothelial cell-expressed prion protein doppel promotes angiogenesis and blood-brain barrier development.

Authors:  Zhihua Chen; John E Morales; Naze Avci; Paola A Guerrero; Ganesh Rao; Je Hoon Seo; Joseph H McCarty
Journal:  Development       Date:  2020-09-23       Impact factor: 6.862

9.  Dexamethasone and Glucocorticoid-Induced Matrix Temporally Modulate Key Integrins, Caveolins, Contractility, and Stiffness in Human Trabecular Meshwork Cells.

Authors:  Felix Yemanyi; Hasna Baidouri; Alan R Burns; VijayKrishna Raghunathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

10.  Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.

Authors:  John M Lattier; Arpan De; Zhihua Chen; John E Morales; Frederick F Lang; Jason T Huse; Joseph H McCarty
Journal:  Oncogene       Date:  2020-10-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.